Status:

COMPLETED

The Effect of Neutral Peritoneal Dialysis (PD) Solution With Minimal Glucose-Degradation-Product (GDP) on Fluid Status and Body Composition

Lead Sponsor:

Chinese University of Hong Kong

Conditions:

Renal Failure

ESRD

Eligibility:

All Genders

18-80 years

Phase:

PHASE4

Brief Summary

Chronic utilization of bio-incompatible peritoneal dialysis (PD) solution has been implicated as a cause of progressive loss of peritoneal permeability and recurrent fluid overload in PD patients. Pre...

Detailed Description

(see above)

Eligibility Criteria

Inclusion

  • new adult continuous ambulatory peritoneal dialysis (CAPD) patients, both diabetic and non-diabetic

Exclusion

  • unlikely to survive, planned to have elective living-related kidney transplant, or transfer to other renal center within 6 months

Key Trial Info

Start Date :

September 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2014

Estimated Enrollment :

68 Patients enrolled

Trial Details

Trial ID

NCT00966615

Start Date

September 1 2010

End Date

September 1 2014

Last Update

September 8 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Medicine & Therapeutics, Prince of Wales Hospital

Shatin, Hong Kong